• 2428 Citations
  • 26 h-Index
1984 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Rita Falcioni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Integrins Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Integrin alpha6beta4 Medicine & Life Sciences
Monoclonal Antibodies Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Phosphatidylinositol 3-Kinase Medicine & Life Sciences
Apoptosis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2018

  • 2428 Citations
  • 26 h-Index
  • 57 Article

Endometrial cancer prognosis correlates with the expression of L1CAM and miR34a biomarkers

Corrado, G., Laquintana, V., Loria, R., Carosi, M., Salvo, L. D., Sperduti, I., Zampa, A., Cicchillitti, L., Piaggio, G., Cutillo, G., Falcioni, R. & Vizza, E., Jul 6 2018, In : Journal of experimental & clinical cancer research : CR. 37, 1, p. 139

Research output: Contribution to journalArticle

Neural Cell Adhesion Molecule L1
Endometrial Neoplasms
Biomarkers
Recurrence
Neoplasms

Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma

Di Martile, M., Desideri, M., Tupone, M. G., Buglioni, S., Antoniani, B., Mastroiorio, C., Falcioni, R., Ferraresi, V., Baldini, N., Biagini, R., Milella, M., Trisciuoglio, D. & Del Bufalo, D., Feb 23 2018, In : Oncogenesis. 7, 2, p. 1-14 14 p.

Research output: Contribution to journalArticle

Histone Deacetylase Inhibitors
Sarcoma
Doxorubicin
Apoptosis
Cell Death
3 Citations (Scopus)

Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma

Di Martile, M., Desideri, M., Tupone, M. G., Buglioni, S., Antoniani, B., Mastroiorio, C., Falcioni, R., Ferraresi, V., Baldini, N., Biagini, R., Milella, M., Trisciuoglio, D. & Del Bufalo, D., Feb 1 2018, In : Oncogenesis. 7, 2, 20.

Research output: Contribution to journalArticle

Histone Deacetylase Inhibitors
Sarcoma
Doxorubicin
Apoptosis
Cell Death
4 Citations (Scopus)

HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance

Loria, R., Laquintana, V., Bon, G., Trisciuoglio, D., Frapolli, R., Covello, R., Amoreo, C. A., Ferraresi, V., Zoccali, C., Novello, M., Del Bufalo, D., Milella, M., Biagini, R., D’Incalci, M. & Falcioni, R., Nov 8 2018, In : Oncogene. 37, 45, p. 5926-5938 13 p.

Research output: Contribution to journalArticle

trabectedin
Liposarcoma
Myxoid Liposarcoma
Vimentin
Therapeutics
12 Citations (Scopus)

Prognostic role of NF-YA splicing isoforms and Lamin A status in low grade endometrial cancer

Cicchillitti, L., Corrado, G., Carosi, M., Dabrowska, M. E., Loria, R., Falcioni, R., Cutillo, G., Piaggio, G. & Vizza, E., 2017, In : Oncotarget. 8, 5, p. 7935-7945 11 p.

Research output: Contribution to journalArticle

Lamin Type A
Endometrial Neoplasms
Protein Isoforms
Paraffin
Formaldehyde